Status:

COMPLETED

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

Lead Sponsor:

Institut Català d'Oncologia

Conditions:

Locally Advanced or Metastatic Melanoma

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

The investigators will evaluate the safety of a single endovenous infusion of ICOVIR5 in adults with locally advanced and metastatic melanoma. ICOVIR5 consists in a conditionally replicative or oncoly...

Eligibility Criteria

Inclusion

  • Malignant melanoma advanced or metastatic.
  • Other than 18 years
  • Karnofsky index \> 60 %
  • Life expectancy \> 3 months
  • ALT/AST \<=2.5 times the upper normal limit
  • Creatinine clearance \>= 50 ml/min.
  • Bilirubin \<25 umol/l
  • Alkaline phosphatase \<= 2.5 time upper normal limit
  • Normal bone marrow function: Neutrophils \>=1.5 E9/L, platelets \>= 1E11/L, hemoglobin \>= 100 g/l, Normal prothrombin time and thromboplastin time,
  • HIV negative
  • Measurable disease
  • Signed informed consent.

Exclusion

  • Geographical, social or psychological conditions that may impair the protocol compliance.
  • Active infections or other severe medical status.
  • History of liver disease.
  • Other or concomitant treatments for melanoma or investigational product.
  • Previous participation in studies with adenovirus.
  • Virus diseases diagnosed two weeks before inclusion.
  • Immunosuppressive concomitant treatments
  • Concomitant malignant haematological disease.
  • Patients having family members with immunodeficient status or disease
  • Patients with Li Fraumeni syndrome or germinal retinoblastoma gene defects.

Key Trial Info

Start Date :

January 11 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 26 2017

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT01864759

Start Date

January 11 2013

End Date

April 26 2017

Last Update

August 29 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut Català d'Oncologia - L'Hospitalet

L'Hospitalet Del Llobregat, Barcelona, Spain, 08908